Dow Jones

40 211,72

0,00%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

INSM

Insmed (INSM)

Insmed Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:INSM

<< Précédent 13 14 15 16 17 18 19 20 21 22 23

Date	Heure	Source	Titre	Symbole	Société
29/09/2005	22h05	Business Wire	Insmed Provides Update on iPlex Pivotal Trial Data in Severe Primary IGF-1 Deficiency	NASDAQ:INSM	Insmed Inc
29/09/2005	12h45	Business Wire	Insmed Issues Statement Regarding IPLEX(TM) Approvable Letter Press Release	NASDAQ:INSM	Insmed Inc
28/09/2005	00h55	Business Wire	Insmed Receives Approvable Letter for iPlex(TM); Conference Call Tomorrow at 8:00am EST	NASDAQ:INSM	Insmed Inc
19/09/2005	15h42	Business Wire	SomatoKine(R) Pivotal Data to Be Featured in a Podium Presentation at the ESPE/LWPES 7th Joint Meeting of Pediatric Endocriniolo	NASDAQ:INSM	Insmed Inc
08/08/2005	22h05	Business Wire	Insmed Incorporated Reports Financial Results for the Second Quarter and First Half of 2005	NASDAQ:INSM	Insmed Inc
02/08/2005	13h00	Business Wire	Insmed to Release Second Quarter Financial Results; Monday, August 8	NASDAQ:INSM	Insmed Inc
10/06/2005	13h14	Business Wire	FDA Extends PDUFA Date for SomatoKine to October 03, 2005	NASDAQ:INSM	Insmed Inc
31/05/2005	22h05	Business Wire	Insmed Reports Detailed Positive Results from Its Pivotal Clinical Trial of SomatoKine in Patients with Growth Hormone Insensiti	NASDAQ:INSM	Insmed Inc
12/05/2005	15h59	PR Newswire (US)	/C O R R E C T I O N -- Insmed Inc./	NASDAQ:INSM	Insmed Inc
11/05/2005	00h00	PR Newswire (US)	Insmed Incorporated Reports Financial Results for First Quarter of 2005	NASDAQ:INSM	Insmed Inc
05/05/2005	15h01	PR Newswire (US)	Insmed Inc. to Webcast First Quarter Earnings Conference Call Thursday, May 12 at 8:30 a.m. (ET)	NASDAQ:INSM	Insmed Inc
26/04/2005	15h30	PR Newswire (US)	Insmed Initiates Phase II Trial With SomatoKine(R) in Type A Extreme Insulin Resistance	NASDAQ:INSM	Insmed Inc
20/04/2005	15h01	PR Newswire (US)	Insmed Initiates Phase II HIV-Associated Lipodystrophy Trial With Somatokine(R)	NASDAQ:INSM	Insmed Inc
18/04/2005	22h03	PR Newswire (US)	Patent Infringement Suit Against Insmed Dismissed	NASDAQ:INSM	Insmed Inc
26/10/2004	01h01	PR Newswire (US)	Insmed Receives European Orphan Drug Designation for SomatoKine for the Treatment of Extreme Insulin Resistance; Company to Init	NASDAQ:INSM	Insmed Inc
21/10/2004	23h01	PR Newswire (US)	Insmed and Tzamal Pharma Announce Agreement for the Promotion and Distribution of SomatoKine in Middle Eastern Territories; Tzam	NASDAQ:INSM	Insmed Inc